Sandu Pharmaceutical has informed that a Meeting of the Board of Directors of the Company will be held on Friday, the 11th day of August, 2017 at 5.00 p.m at the Corporate Office of the Company at Sandu Pharmaceuticals Limited, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071 to approve Unaudited Financial Results of the Company for the Quarter Ended 30th June 2017. In Compliance with the Company’s Code of Conduct for prevention of Insider Trading devised as per the SEBI (Prohibition of Insider Trading) Regulations, 1992, amended till date the company also informed that the trading window for dealing in the Securities of the Company shall be closed for the Company’s Directors/Officer and designated employees of the Company from the opening of Trading hours on Wednesday, 02nd day of August 2017 till 48 hours after announcement of financial results to public in compliances with the code of conduct for prevention of Insider.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: